CLASS II Device recall · Reported 6 Feb 2013 · FDA Enforcement Report

Mindray DPM5 Monitor, a vital signs monitor used on human recalled

Mindray DS USA, Inc. d.b.a. Mindray North America is recalling Mindray DPM5 Monitor, a vital signs monitor used on human patients in healthcare, distributed nationwide in the US. The recall was initiated on 5 Sep 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesp/n 9201F-PA000XX DS- 0C000565 02000335 12000603 12000599 12000597 OCOOO569 9A000247 9A000252 17000648 06000490 05000470 05000466 02000373
Quantity recalled13 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0742-2013
FDA event ID
63800
Classification
Class II
Status
Terminated
Recall initiated
5 Sep 2012
FDA classified
27 Jan 2013
Reported
6 Feb 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Patient Monitors

Timeline

5 Sep 2012Recall initiated by company
27 Jan 2013Classified by FDA+144 days
6 Feb 2013Published in enforcement report+10 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Mindray has identified an issue with the DPM5 monitors where ST and Arrhythmia features may not be available.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Mindray DPM5 Monitor, a vital signs monitor used on human patients in healthcare facilities.

Where it was distributed

US Nationwide Distribution including the states of: VA, TN, FL, & TX

Nationwide FloridaTennesseeTexasVirginia

Questions about this recall

Why was it recalled?

Mindray has identified an issue with the DPM5 monitors where ST and Arrhythmia features may not be available.

Which lots are affected?

p/n 9201F-PA000XX DS- 0C000565 02000335 12000603 12000599 12000597 OCOOO569 9A000247 9A000252 17000648 06000490 05000470 05000466 02000373

Where was it sold?

US Nationwide Distribution including the states of: VA, TN, FL, & TX

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Mindray DS USA, Inc. d.b.a. Mindray North America

All 9

Other Patient Monitors recalls

All 1,013